N. Masubuchi et al., EFFECTS OF PROTON PUMP INHIBITORS ON THYROID-HORMONE METABOLISM IN RATS - A COMPARISON OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION, Biochemical pharmacology, 54(11), 1997, pp. 1225-1231
The effects of proton pump inhibitors on thyroid hormone metabolism in
rats were examined. Pantoprazole, omeprazole, and lansoprazole were a
dministered repeatedly to female SD rats at doses of 5, 50, and 300 mg
/kg/day for 1 week, and changes in UDP-glucuronyltransferase activitie
s were examined. Increases in o-aminophenol UDP-glucuronyltransferase
activity, which was measured as that responsible for the glucuronidati
on of thyroxine, were evident following 7-day high-dose administration
of all the proton pump inhibitors tested. Of the three proton pump in
hibitors investigated, o-aminophenol UDP-glucuronyltransferase activit
y was est following the high-dose administration of omeprazole. Andros
terone UDP-glucuronyltransferase activity in rats treated with the pro
ton pump inhibitors increased significantly, but these increases were
smaller than those of o-aminophenol UDP-glucuronyltransferase. Pantopr
azole and omeprazole treatment did not affect plasma T-4 or T-3 signif
icantly, whereas lansoprazole treatment produced marked reductions in
plasma T-4 but did not affect plasma T-3 significantly. After administ
ration of I-125-labeled thyroid hormone to rats treated with the proto
n pump inhibitors, biliary excretion of radioactivity increased signif
icantly in omeprazole-and lansoprazole-treated rats; these increases w
ere attributed to induction of liver thyroxine UDP-glucuronyltransfera
se activities. The order of biliary excretion of radioactivity, as wel
l as the o-aminophenol UDP-glucuronyltransferase activity, in the trea
ted animals was: omeprazole > lansoprazole > pantoprazole. Therefore,
repeated administration of the proton pump inhibitors increased thyrox
ine-metabolizing activity via induction of UDP-glucuronyltransferase,
and this induction by pantoprazole was less pronounced than that by om
eprazole or lansoprazole. (C) 1997 Elsevier Science Inc.